PF-06700841
Drug timelines are a Plus or Pro feature.
11 regulatory and trial events tracked for PF-06700841, covering 2017-03-08 to 2024-10-30. Get the full timeline:
Most recent: Clinical Trial Update: Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's Disease [Phase 2]